CA2069404A1 - Utilisation de s(-) atenolol pur optiquement pour le traitement de troubles cardio-vasculaires - Google Patents

Utilisation de s(-) atenolol pur optiquement pour le traitement de troubles cardio-vasculaires

Info

Publication number
CA2069404A1
CA2069404A1 CA002069404A CA2069404A CA2069404A1 CA 2069404 A1 CA2069404 A1 CA 2069404A1 CA 002069404 A CA002069404 A CA 002069404A CA 2069404 A CA2069404 A CA 2069404A CA 2069404 A1 CA2069404 A1 CA 2069404A1
Authority
CA
Canada
Prior art keywords
atenolol
beta
medicament
treatment
cardiovascular disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002069404A
Other languages
English (en)
Inventor
Timothy J. Barberich
Robert L. Bratzler
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2069404A1 publication Critical patent/CA2069404A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002069404A 1989-11-21 1990-11-21 Utilisation de s(-) atenolol pur optiquement pour le traitement de troubles cardio-vasculaires Abandoned CA2069404A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44003689A 1989-11-21 1989-11-21
US440,036 1989-11-21

Publications (1)

Publication Number Publication Date
CA2069404A1 true CA2069404A1 (fr) 1991-05-22

Family

ID=23747155

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002069404A Abandoned CA2069404A1 (fr) 1989-11-21 1990-11-21 Utilisation de s(-) atenolol pur optiquement pour le traitement de troubles cardio-vasculaires

Country Status (5)

Country Link
EP (1) EP0519925A1 (fr)
JP (1) JPH05503510A (fr)
AU (1) AU643487B2 (fr)
CA (1) CA2069404A1 (fr)
WO (1) WO1991007175A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000074A1 (fr) * 1991-06-26 1993-01-07 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur r(+)
EP1262182A3 (fr) * 1991-11-26 2003-02-26 Sepracor Inc. Procédés et compositions destinés à traiter l'hypertension, l'angine de poitrine et d'autres troubles à l'aide de (-) amlodipine optiquement pure
ATE457169T1 (de) * 1998-10-15 2010-02-15 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
WO2000051582A2 (fr) 1999-03-01 2000-09-08 Sepracor Inc. Procedes de traitement de l'apnee et de troubles de l'apnee a l'aide de r(+) ondansetron optiquement pur
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62245353A (ja) * 1986-04-18 1987-10-26 Hitachi Ltd Ｅｅｐｒｏｍのデ−タ書換え防止回路
JPS62271031A (ja) * 1986-05-20 1987-11-25 Fujitsu Ltd 記憶デ−タ保護方式
GB8618324D0 (en) * 1986-07-28 1986-09-03 Shell Int Research Phenylacetate/atenolol

Also Published As

Publication number Publication date
WO1991007175A1 (fr) 1991-05-30
AU643487B2 (en) 1993-11-18
JPH05503510A (ja) 1993-06-10
EP0519925A1 (fr) 1992-12-30
AU6893391A (en) 1991-06-13

Similar Documents

Publication Publication Date Title
FRISHMAN Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts
WO1993017677A1 (fr) Procedes antipyretiques et analgesiques et compositions contenant du cetoprofene r(-) pur sur le plan optique
US5998467A (en) Medicine for oculopathy
US4330558A (en) Pharmaceutical composition and method for treating peripheral orthostatic hypotension
US5508279A (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia
AU643487B2 (en) Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
US4699928A (en) Fluoroallylamine derivatives
US4389415A (en) Method of treating hypertension
JPH0530823B2 (fr)
Estafanous et al. Arterial hypertension in immediate postoperative period after valve replacement.
AU2022247120A1 (en) Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative
JPH0466477B2 (fr)
BE1000265A3 (fr) Nouvelle association medicamenteuse.
US4346110A (en) Method for treating depression
EP0163683A1 (fr) Derives de l'acide chromone-2-carboxylique utilises comme agents cardio-vasculaires
WO1993000081A1 (fr) Nadolol s(-) optiquement pur utilise dans le traitement des troubles cardio-vasculaires
Adams Adrenergic agonists and antagonists
WO1994009783A1 (fr) Procedes et compositions contenant de la doxazosine (-) utilises dans le traitement de l'adenome prostatique et de l'atherosclerose
HUP0201650A2 (hu) Amino-tetralin-származékok alkalmazása szív- és érrendszeri betegségek gyógykezelésére használható gyógyszerek előállítására
RU2858684C2 (ru) Новое применение производного 3-(4-(бензилокси)фенил)гекс-4-иновой кислоты
LU85371A1 (fr) Procede de traitement antiarythmique de classe iii
PL113904B1 (en) Process for preparing novel derivatives of indolysine
US4786634A (en) Method for treating arteriosclerosis
JPS6245525A (ja) 脂質低下剤
FR2787328A1 (fr) Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures

Legal Events

Date Code Title Description
FZDE Dead